Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | MGMT promoter methylation status
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > MGMT promoter methylation status
*Hegi ME, Oppong FB, Perry JR, Wick W, Henriksson R, Laperriere
NJ, Gorlia T, Malmström A, Weller M; NCBTSG; NOA; CCTG;
EORTC-BTG.
No benefit from TMZ
treatment in GB with truly unmethylated MGMT promoter: Reanalysis
of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB
patients.
Neuro
Oncol. 2024 Jun 24:noae108. doi:
10.1093/neuonc/noae108. PMID:
38912869. Observational study. ˍ